Hillrom to Buy Bardy Diagnostics for $375M, Deal to Close in Q2 with Possible Milestone Payments

Hillrom will acquire Seattle-based Bardy Diagnostics for $375 million, adding Bardy’s week-long CAM cardiac monitor and related cardiology products to its portfolio; the deal may include future milestone payments and is expected to close in Q2. Bardy, founded in 2013, has about $30 million in annualized revenue, over $20 million in net operating losses, roughly 230 employees, and has raised more than $71 million to date.

UUniversity of Washington